Objective Although metabolic syndrome (MS) is considered to be a predictor of diabetes and cardiovascular disease, its value for predicting diabetes beyond the levels of fasting glucose (FG) and hemoglobin A1c (HbA1c) remains questionable. In this study, we evaluated the usefulness of MS and Japanese MS (JMS) as predictors of diabetes. Methods This study is a longitudinal study using data for 2,034 subjects who visited our Medical Check-up Center in both 2008 and 2011 and were free from diabetes at baseline. The odds ratios (ORs) of developing diabetes in 2011 for MS and JMS were calculated after being adjusted for FG, age, sex and antihypertensive and antihyperlipidemic medication use, then further adjusted for HbA1c. The optimal cutoff points for FG, HbA1c and body mass index (BMI) to discriminate the development of diabetes and their sensitivities/specificities were obtained from receiver operating characteristic curves. These sensitivities/specificities were compared with the sensitivities/specificities of MS and JMS. Results The ORs (95% confidence intervals (CIs)) of developing diabetes for MS and JMS were 1.36 (0.57-3.23) (p=0.484) and 3.23 (1.25-8.36) (p=0.016), respectively, after being adjusted for FG and 1.06 (0.39-2.86) (p=0.915) and 2.34 (0.79-6.95) (p=0.126), respectively, after being further adjusted for HbA1c. The sensitivities/specificities of FG, HbA1c, BMI, MS and JMS were 0.625/0.897, 0.828/0/919, 0.625/0.734, 0.375/0.911, and 0.375/0.941, respectively. Conclusion MS and JMS were found to be poor predictors of diabetes in a Japanese health screening population.
Introduction
Metabolic syndrome (MS) (1-7) is considered to be a risk factor for diabetes and cardiovascular disease (CVD). However, its value for predicting diabetes beyond the level of fasting glucose (FG) is questioned (8) (9) (10) . The American Diabetes Association and the European Association for the Study of Diabetes have criticized the antinomy that MS criteria include diabetes per se (2) . The World Health Organization Expert Consultation Group reported that MS is a concept that focuses attention on complex multifactorial health problems but has limited practical utility as a diagnostic or management tool and limited utility in epidemiological studies (6) . MS is a premorbid condition rather than a clinical diagnosis (6) . Cameron et al. reported that MS is not a better predictor of diabetes than FG and that the risk of developing diabetes among patients with prediabetes but not MS is almost triple that of those with MS but not prediabetes (10) . On the other hand, the usefulness of hemoglobin A1c (HbA1c) for predicting diabetes has been reported in several studies (11) (12) (13) . In the present study, we evaluated the usefulness of MS and Japanese MS (JMS) (14) as predictors of diabetes compared with the levels of FG and HbA1c in a Japanese health screening population.
Materials and Methods

Study subjects
The present study involved 1,290 men and 744 women who visited our Medical Check-up Center for health screening in both 2008 and 2011, were free from diabetes in 2008 and provided signed informed consent. All visitors were required to fill out a questionnaire created by the Ministry of Health, Labour and Welfare for the purpose of the Special Health Examination and Instruction, including questions regarding any history of stroke or coronary heart disease (CHD), smoking status and antihypertensive, antidiabetic or antihyperlipidemic medication use. Diabetes was defined as an FG level ! 126 mg/dL, an HbA1c level ! 6.5% and/or the use of antidiabetic medications. The values of HbA1c are expressed in NGSP%.
Measurements
After an overnight fast, blood samples were obtained to measure the levels of FG, HbA1c, triglycerides and highdensity lipoprotein (HDL) cholesterol. All chemical measurements were obtained at BML Nagaoka (Nagaoka, Japan). The average systolic blood pressure (SBP) and diastolic blood pressure (DBP) were calculated from two measurements obtained in a sitting position after a 5-minute rest. Body weight was measured with the subject wearing light clothes provided by our center, and the weight of the clothes was subtracted from the measured body weight. Waist circumference (WC) was measured at the level of the umbilicus in a standing position. The body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters.
Definition of MS and JMS
MS was defined as the clustering of three or more of the following five components according to the harmonizing worldwide criteria (5): 1) abdominal obesity: WC ! 90 cm in men and 80 cm in women according to the recommendation for Japanese individuals by the International Diabetes Federation (IDF) (3), 2) high blood pressure: an SBP ! 130 mmHg, a DBP ! 85 mmHg and/or the use of antihypertensive medications, 3) high triglycerides: triglycerides ! 150 mg/dL, 4) low HDL cholesterol: HDL cholesterol <40 mg/ dL in men and <50 mg/dL in women and 5) high FG: FG ! 100 mg/dL.
JMS was defined as abdominal obesity plus two or more of the following three components (14): 1) high blood pressure: an SBP ! 130 mmHg, a DBP ! 85 mmHg and/or the use of antihypertensive medications, 2) dyslipidemia: triglycerides ! 150 mg/dL and/or HDL cholesterol <40 mg/dL and 3) high FG: FG ! 110 mg/dL. For the JMS criteria, abdominal obesity was defined as WC ! 85 cm in men and ! 90 cm in women according to the Examination Committee of the Criteria for "Obesity disease" in Japan (15) .
Upon diagnosing metabolic syndrome, subjects receiving antihypertensive medications were included in the high blood pressure group; however, antihyperlipidemic medications were ignored because exact information regarding antihyperlipidemic drugs was not available.
Statistical analysis
The odds ratios (ORs) of developing diabetes for MS and JMS were calculated after being adjusted for 1) Model 1: age, sex and use of antihypertensive or antihyperlipidemic medications, 2) Model 2: the covariates in Model 1 plus FG, 3) Model 3: the covariates in Model 2 plus HbA1c, 4) Model 4: the covariates in Model 1 plus a dichotomous FG ! 102 mg/dL and 5) Model 5: the covariates in Model 4 plus a dichotomous HbA1c ! 5.8%. The optimal cutoff points (OPCs) for FG, HbA1c and BMI to discriminate the development of diabetes and the sensitivities/specificities were obtained from receiver operating characteristic (ROC) curves, and the sensitivities/specificities were compared with those of MS and JMS. All calculations were performed using the Dr SPSS-2 software program (IBM Japan, Tokyo, Japan). The means were compared using two-sided t-tests and the prevalence of each valuable was compared using the chi-squared test. p values of less than 0.05 were considered to be statistically significant.
This study was approved by the ethics committee of the Tachikawa Medical Center. Table 1 stratified according to whether the subjects developed diabetes. The mean BMI, WC, SBP, DBP, triglycerides, FG, and HbA1c and the frequencies of MS, JMS, antihypertensive and antihyperlipidemic medication use and a history of stroke were significantly higher and the mean HDL cholesterol was significantly lower in the subjects who developed diabetes than in those who did not.
Results
The ORs of developing diabetes for MS and JMS are presented in Table 2 Table 3 for the numerical data. the covariates in Model 4 plus HbA1c ! 5.8% (Model 5).
The ROC curves of FG, HbA1c and BMI for the discrimination of developing diabetes are shown in Figure. Judged from the ROC curves, HbA1c appeared to be the best discriminator. The sensitivities/specificities of FG, HbA1c, BMI, MS, and JMS and the AUCs and OCPs of FG, HbA1c, and BMI for the discrimination of developing diabetes are presented in Table 3 
Discussion
The present study demonstrated that MS and JMS, which include the FG level as a component, were poor predictors of diabetes and not significant predictors after being adjusted for the levels of FG and HbA1c in a Japanese health screening population. Although MS and JMS exhibited high specificities for predicting future diabetes (-90%), their sensitivities were low (-38%), while prediction by FG ! 102 mg/ dL and HbA1c ! 5.8% exhibited higher sensitivities (-63% or -83%, respectively), with similar specificities (-90%). The OR of developing diabetes for JMS was slightly higher than that for MS. This may be due to the higher cut-off point for the high FG component in JMS than in MS. However, the differences in the ORs between MS and JMS were not significant and the sensitivities/specificities of MS and JMS for the discrimination of developing diabetes were almost equal.
The value of MS for predicting incident diabetes beyond the FG level is questioned (8-10). Ford et al. reviewed prospective studies examining the association between MS and incident diabetes (8) . The relative risk of incident diabetes ranges from 3.53 to 5.17 in various definitions of MS (8) . The AUCs of MS for predicting incident diabetes range from 0.68 to 0.85 (8) . The authors concluded that limited evidence suggests that FG alone may be as good as MS for predicting diabetes and that the clinical value of MS for diabetes prediction remains uncertain, although MS exhibits a stronger association with incident diabetes than with CVD (8). Cheung et al. studied the association between MS and incident diabetes in Chinese subjects and reported that the hazard ratios (HRs) (95% CIs) for the National Cholesterol Education Program (1) and IDF (3) definitions of MS were 4.1 (2.8-6.09) and 3.5 (2.3-5.29), respectively, while the HRs (95% CIs) for FG ! 110 mg/dL and FG ! 100 mg/ dL were 6.9 (4.1-11.5) and 4.1 (2.8-6.0), respectively (9). Cameron et al. compared the ability of MS, a diabetes prediction model (DPM), a noninvasive risk questionnaire and the FG level to predict incident diabetes in a five-year cohort study of an adult Australian population (10). MS was not found to be a better predictor of incident diabetes than (16) . The authors suggested that MS significantly increases the risk of incident diabetes independent of the FG level, and is therefore a valuable tool for identifying individuals at high risk of developing diabetes. However, they did not measure the HbA1c levels and did not compare the discriminative ability to predict incident diabetes with the sensitivities/specificities (16) . In our present study, the HbA1c level was suggested to be the best discriminator of developing diabetes judged from the ROC curve, although the 95% CIs of the AUCs were overlapping. The level of HbA1c has been suggested to be superior to that of FG in predicting CVD and death from any cause (17, 18) . Cheng et al. studied the diabetes predicting ability of HbA1c and reported that HbA1c increments of 0.5% between 5.0% and 6.4% had adjusted ORs of 1.70 (5.0-5.4%), 4.87 (5.5-5.9%), and 16.06 (6.0-6.4%) when compared with the reference group of HbA1c <4.5% in an eight-year follow-up study (11) . Choi et al. also evaluated the usefulness of the HbA1c level as a predictor of incident diabetes and reported that the OCP and sensitivity/specificity of HbA1c were 5.6% and 0.59/0.77, respectively, in a sixyear follow-up study among Korean subjects (12) . In our present study, the OCP and sensitivity/specificity of HbA1c were 5.8% and 0.828/0/919, respectively. Heianza et al. reported that diagnosing prediabetes based on both the HbA1c criterion (5.7-6.4%) and the FG criterion (100-125 mg/dL) identified individuals with an increased risk of developing diabetes and that the predictive value assessed with HbA1c 5·7-6·4% alone was similar to that assessed with FG 100-125 mg/dL alone in a Japanese health screening population (13) . In their study, the AUC (95% CI) of HbA1c was 0.795 (0.767-0.822), which was inferior to that of FG and lower than that of HbA1c in our current study. The reason for this discrepancy is unknown. However, the difference in discrimination ability between HbA1c and FG was not significant because the 95% CIs of their AUCs overlapped.
Limitations
The subjects in the present study were not recruited from the general population but from a health screening population. However, it is unlikely that the relationship between MS and incident diabetes is substantially different between the general population and health screening populations. The diagnosis of diabetes was not based on oral glucose tolerance tests but rather on one point measurements of FG or HbA1c, which although recommended for epidemiological studies by the Japanese Diabetes Society (19) , has an intrinsic limitation in large epidemiological studies. The present study included data for each subject at only two time points and subjects who dropped-out were ignored. However, it is unlikely that a random drop-out phenomenon brought a significant bias to the ORs or AUCs of developing diabetes for MS and JMS.
Conclusion
MS and JMS were found to be poor predictors of diabetes compared with the levels of FG or HbA1c in a Japanese health screening population. A diagnosis of MS or JMS may not necessarily predict future diabetes. In contrast, the HbA1c level is suggested to be a very useful predictor of future diabetes.
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